Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

NEC Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

VIEWS: 20 PAGES: 42

ICD Research's "NEC Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.

More Info
									NEC Corporation

_________________________________________________________________________________



NEC Corporation                                                              Financial Snapshot

                                                                             Operating Performance
Fast Facts
                                      7-1, Shiba 5-chome,, Minato-ku, 108-   The company reported revenue of US$35,471.07
Headquarters Address
                                      8001,Japan                             million during the fiscal year 2011 (2011). The
                                                                             company's revenue declined at a compounded rate of
Telephone                             + 81 3 34541111
                                                                             2.65% during 2007–2011, with an annual decline of
                                                                             13.05% over 2010. In 2011, the company recorded an
Fax                                   N/A                                    operating margin of 1.24%, as against 0.69% in 2010.

Website                               N/A
                                                                             Revenue and Margins
Ticker Symbol, Stock Exchange         6701, American Stock Exchange

Number of Employees                   115,840

Fiscal Year End                       March

Revenue (in US$ million)              35,471.07

Revenue (in JPY million)              3,115,424.00




SWOT Analysis                                                                Return on Equity

Strengths                             Weaknesses                             The company recorded a return on equity (ROE) of -
                                                                             1.65% for 2011, as compared to its peers, Hitachi,
Broad product portfolio               Contingent liabilities                 Ltd. (Ticker: 6501), Toshiba Corporation (Ticker:
                                                                             6502) and Kanematsu Electronics Ltd. (Ticker: 8096),
                                                                             which recorded ROEs of 16.59%, 15.88% and 7.35%
Focused R&D activities                Weak top-line performance              respectively. The company reported an operating
                                                                             margin of 1.24% in 2011.
Opportunities                         Threats
Growth potential for semiconductor                                           Return on Equity
                                      Alternative technologies
market

Rising demand for smartphones         Foreign exchange risk

Strategic partnership with NetSuite   Rapid technological changes




                                                                             Liquidity Position

                                                                             The company reported a current ratio of 1.22 in 2011,
                                                                             as compared to its peers, Hitachi, Ltd., Toshiba
                                                                             Corporation and Kanematsu Electronics Ltd., which
                                                                             recorded current ratios of 1.20, 1.12 and 4.10
                                                                             respectively. As of March 2011, the company
                                                                             recorded cash and short-term investments of worth
                                                                             US$2,338.83 million, against US$1,262.83 million
                                                                             current debt. The company reported a debt to equity
                                                                             ratio of 0.87 in 2011 as compared to its peers, Hitachi,
                                                                             Ltd., Toshiba Corporation and Kanematsu Electronics
                                                                             Ltd., which recorded debt to equity ratios of 1.48, 1.25
                                                                             and 0.00 respectively.




___________________________________________________________________________________________

NEC Corporation - SWOT Profile                                                                                        Page 1
NEC Corporation

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 8
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................8
    2.2       Key Financial Performance Indicators .................................................................................................................11
      2.2.1       Revenue and Operating Profit .........................................................................................................................11
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................12
      2.2.3       Net Debt vs. Gearing Ratio ..............................................................................................................................13
      2.2.4       Operational Efficiency ......................................................................................................................................14
      2.2.5       Solvency ..........................................................................................................................................................15
      2.2.6       Valuation ..........................................................................................................................................................16
    2.3       Competitive Benchmarking ..................................................................................................................................17
      2.3.1       Market Capitalization .......................................................................................................................................17
      2.3.2       Efficiency ..........................................................................................................................................................18
      2.3.3       Capital Expenditure ..........................................................................................................................................19
      2.3.4       Turnover – Inventory and Asset .......................................................................................................................20
3     Mergers & Acquisitions and Partnerships ........................................................................................... 21
    3.1       M&A and Partnerships Strategy ...........................................................................................................................21
4     Recent Developments ........................................................................................................................... 24
5     SWOT Analysis ...................................................................................................................................... 26
    5.1       SWOT Analysis - Overview ................................................................................................................................
								
To top